How Should Marrow Transplantation be Approached?
Marrow transplantation is no longer a last desperate effort aimed only at salvaging patients with far advanced disease. Marrow transplantation in 1988 is a well established modality, which may acutally represent the treatment of choice for a given patient, and hence, should be part of treatment planning early in the patient’s course. This can be a demanding task, but the approach is generally rewarding both for physicians and patients. There must be no misunderstanding: marrow transplantation is a complex and expensive therapy. Results depend upon factors such as disease stage, patient age, histocompatibility, possibly donor age, and the patient’s overall medical condition. Some transplants, especially autologous, are still considered experimental and may not be covered by health insurance. Early recognition and discussion of potential problems may allow for them to be resolved, may direct therapeutic efforts in different directions, or may provide time needed to assure financing.
KeywordsAcute Lymphoblastic Leukemia Marrow Transplantation Aplastic Anemia Chronic Granulomatous Disease Transplant Center
Unable to display preview. Download preview PDF.
- Champlin R, Gale RP (1987) Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies. Seminars in Hematol 24: 55Google Scholar
- Gluckman E, Berger R, Dutreix J (1984) Bone marrow transplantation for Fanconi anemia. Seminars in Hemat 21: 20Google Scholar
- Herzig RH, Bortin MM, Barrett AJ, Blume KG, Gluckman E, Horowitz MM, Jacobsen SJ, Marmont A, Masaoka T, Prentice HG, Ramsay NK, Rimm AA, Ringden O, Speck B, Zwaan FE, Gale RP (1987) Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission. The Lancet, I 786CrossRefGoogle Scholar
- Hoelzer D, Thiel E, Loffler H, Bodenstein H, Plaumann L, Buchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Muller U, Wendt FC, Sodomann H, Ruhl H, Herrmann F, Kaboth W, Dietzfelbinger H, Pralle H, Lunscken Ch, Hellriegel K-P, Spors S, Nowrousian RM, Fischer J, Fulle H, Mitrou PS, Pfreundschuh M, Gorg Ch, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, Konig H, Mainzer K, Herrmann R, Messerer D, Zwingers T (1984) Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64: 38PubMedGoogle Scholar
- Lucarelli G, Izzi T, Porcellini A, Delfini C, Galimberti M, Polchi P, Moretti L, Manna A, Sparaventi G (1983) Fetal liver transplant in aplastic anemia and acute leukemia. Recent Advances in Bone Marrow Transplantation R.P. Gale (ed.) Alan R. Liss, Inc. New York pp. 865Google Scholar
- Phillips GL, Herzig RH, Lazarus HM, Fay JW, Wolff SN, Mill WB, Lin HS, Thomas PR, Glasgow GP, Shina DC, Herzig GP (1984) Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. New Eng J Med 310: 1157CrossRefGoogle Scholar
- Preisler H, Davis RB, Kirshner J, Dupre E, Richards F, Hoagland HC, Kopel S, Levy RN, Carey R, Schulman P, Gottlieb AJ, Mclntyre OR, and the Cancer and Leukemia Group B (1987) Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study. Blood, 69: 1441PubMedGoogle Scholar
- Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H, Mellits D, Sensenbrenner LL, Stuart RK, Yeager AM (1983) Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. New Eng J Med 309: 1347PubMedCrossRefGoogle Scholar
- Storb R, Thomas ED, Buckner CD, Appelbaum FR, Clift RA, Deeg HJ, Doney K, Hansen JA, Prentice RL, Sanders JE, Stewart P, Sullivan KM, Witherspoon RP (1984) Marrow transplan tation for aplastic anemia. Seminars in Hemat 21: 27Google Scholar
- Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, Buckner D, Cheever MA, Deeg HJ, Doney K, Flournoy N, Greenberg P, Hansen JA, Martin P, McGuffm R, Ramberg R, Sanders JE, Singer J, Stewart P, Storb R, Sullivan K, Weiden PL, Witherspoon R (1986) Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Int Med 104: 155PubMedGoogle Scholar